Cancer Vaccine Markets Set to Explode Upon Commercialization of New Drugs, Says Frost & Sullivan.Business Editors and Health/Medical Writers SAN JOSE San Jose, city, United States San Jose (sănəzā`, săn hōzā`), city (1990 pop. 782,248), seat of Santa Clara co., W central Calif.; founded 1777, inc. 1850. , Calif.--(BUSINESS WIRE)--Jan. 31, 2001 Commercial approval of cancer vaccines Cancer vaccines A treatment that uses the patient's immune system to attack cancer cells. Mentioned in: Pancreatic Cancer, Exocrine is one of the most eagerly anticipated progressions in modern health care. With a patient population of more than eight million in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. alone, physicians are anxious to try anything that can increase the chances of survival and improve the quality of life for cancer-stricken patients. New strategic healthcare industry research from Frost & Sullivan (www.healthcare.frost.com) indicates that the U.S. markets for cancer vaccines will experience explosive growth in the coming years as products gain approval from the Food and Drug Administration (FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. ). Frost & Sullivan estimates revenues to be roughly $60 million in 2002 with a compound annual growth rate of over 100 percent through 2007. More than 150 vaccines are currently in different stages of development and the years of laboratory research and clinical development are finally reaching the commercialization stage. The FDA, however, has yet to approve any of these vaccines. But, there are a number of products currently in Phase III clinical trials Noun 1. phase III clinical trial - a large clinical trial of a treatment or drug that in phase I and phase II has been shown to be efficacious with tolerable side effects; after successful conclusion of these clinical trials it will receive formal approval from the . "The completion of Phase III clinical trials can result in the review and subsequent approval of cancer vaccines by the FDA. But since they have not approved any cancer vaccines, the FDA can be austere in their process," says Frost & Sullivan pharmaceutical industry expert Dhiraj Ajmani. "Due to the uniqueness of each vaccine, it is anticipated that the FDA will evaluate each one on a drug-by-drug basis using the same stringent standards every time." There are currently three cancer vaccines approved in other countries, but the U.S. is very strict and conservative; patient safety is of utmost importance. This results in long approval processes as the FDA ensures that the drugs are safe and efficacious ef·fi·ca·cious adj. Producing or capable of producing a desired effect. See Synonyms at effective. [From Latin effic . Many drugs approved by the FDA are part of a distinct class of drugs that perform the same way. Thus, when one company's product is approved, it usually kicks open the door for all drugs in that class to be approved as well. Cancer vaccines are a bit different. While the mechanics of all these drugs are the same, stimulating the body's immune system immune system Cells, cell products, organs, and structures of the body involved in the detection and destruction of foreign invaders, such as bacteria, viruses, and cancer cells. Immunity is based on the system's ability to launch a defense against such invaders. to fight cancerous cells, each is unique in which type of cancer it treats and how it jump-starts the immune system. "The approval of the first cancer vaccines may open the door for others, yes," states Ajmani. "Nevertheless, each vaccine is unique and thus is expected to be taken on an individual basis and not as a class of drugs." Cancer vaccines are being developed as an adjunct therapy with other cancer treatments such as chemotherapy, radiation or surgery. This means that cancer vaccines can be given to each and every patient provided they are efficacious. This incremental Additional or increased growth, bulk, quantity, number, or value; enlarged. Incremental cost is additional or increased cost of an item or service apart from its actual cost. benefit encourages the adjunctive use and significantly expands the cancer therapeutic market. Frost & Sullivan, which is headquartered in San Jose, Calif., is a global leader in international strategic market consulting and training. Frost & Sullivan's industry experts monitor the pharmaceutical industry for market trends, market measurements and strategies. This ongoing research is used to complement the Pharmaceuticals Market Service available at www.pharma.frost.com. Executive summaries and analyst interviews are available to the press. Along with producing in-depth strategic market consulting research, Frost & Sullivan also provides custom consulting services Noun 1. consulting service - service provided by a professional advisor (e.g., a lawyer or doctor or CPA etc.) service - work done by one person or group that benefits another; "budget separately for goods and services" to a variety of national and international companies. U.S. Cancer Vaccine The term cancer vaccine is often used to describe a process whereby a person's immune system is coaxed into recognizing and destroying malignant cells without harming normal cells. Markets Report: 7539-52 Date: January 2001 |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion